Clinical Trial

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Name: Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD — clinical trial record (NCT06902974)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SUN004

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase 2, Open-Label Study to explore the efficacy, safety, and tolerability of psilocybin-assisted therapy in women with sexual assault-related Posttraumatic Stress Disorder (PTSD).

Protocol Amendment History 1 change

notable Enrollment increased: 35 -> 70 participants 2026-05-16

Trial Details

NCT Number	NCT06902974
Lead Sponsor	Sunstone Medical
Conditions	Post Traumatic Stress Disorder, PTSD
Enrollment	70 participants
Start Date	2026-05-23
Primary Completion	2027-11 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-07-01